Abstract
Chronic infections of bone and joints always have been considered especially difficult to treat, requiring multiple operations with long hospital stays, prolonged antibiotic medication in high dosage, and extended periods of impairment. Still cure often cannot be obtained leading to amputation in many cases. The reasons for infection resistance against conventional antimicrobial therapies have been elucidated only in the last three decades, based on the pioneering work of William Costerton, showing that pathogens may change from the familiar planktonic forms into phenotypically different sessile forms after adhesion to unvascularized surfaces, forming the organized biocoenosis of a biofilm. Biofilm-embedded bacteria are present in all orthopedic infections and require much higher concentrations (up to 1,000 times) of antibiotics for elimination than their planktonic forms. For creating higher local antibiotic concentrations, carriers have been developed, but the frequently used devices made of poly(methyl methacrylate) cannot provide sufficient concentrations in the surrounding tissues and spaces and act as a substrate of biofilm colonization themselves. Antibiofilm substances have been investigated but are not yet available for clinical practice. Presently the only possibility of a biofilm-centered treatment is found in sophisticated techniques of debridement combined with increased antibiotic concentrations at the site of infection. Highly purified bone has been found to be an appropriate tool for storing and delivering the required amount of antibiotics in order to eliminate biofilm remnants after meticulous debridement. Additionally it offers the advantage of reconstructing osseous defects that always are present after surgically treated bone infection. Using antibiotic-impregnated bone graft treatment of infection, reconstruction and internal stabilization may be performed within a single operation. Long hospital stays and treatments associated with prolonged periods of pain and/or reduced mobility may be avoided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ammon P, Stockley I (2004) Allograft bone in two-stage revision of the hip for infection. Is it safe? J Bone Joint Surg Br 86:962–965
Amorena B, Gracia E, Monzón M et al (1999) Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44:43–55
Anwar H, Strap JL, Chen K, Costerton JW (1992) Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother 36:1208–1214
Balaban N, Cirioni O, Giacometti A et al (2007) Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 51:2226–2229
Baleani M, Persson C, Zolezzi C, Andollina A, Borrelli AM, Tigani D (2008) Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty 23:1232–1238
Barcia-Macay M, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F (2006) Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. J Antimicrob Chemother 58:1177–1184
Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P (2004) Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother 53:329–334
Buchholz HW, Engelbrecht H (1970) Depot effects of various antibiotics mixed with Palacos resins. Chirurg 41:511–515
Buttaro MA, Gimenez MI, Greco G, Barcan L, Piccaluga F (2005a) High active local levels of vancomycin without nephrotoxicity released from impacted bone allografts in 20 revision hip arthroplasties. Acta Orthop 76:336–340
Buttaro MA, Pusso R, Piccaluga F (2005b) Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br 87:314–319
Carmen JC, Roeder BL, Nelson JL et al (2005) Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics. Am J Infect Control 33:78–82
Chang CC, Merritt K (1992) Microbial adherence on poly(methyl methacrylate) (PMMA) surfaces. J Biomed Mater Res 26:197–207
Chuard C, Vaudaux P, Waldvogel FA, Lew DP (1993) Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob Agents Chemother 37:625–632
Costerton JW (2005) Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res (437):7–11
Darouiche RO, Dhir A, Miller AJ, Landon GC, Raad II, Musher DM (1994) Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 170:720–723
Dempsey KE, Riggio MP, Lennon A et al (2007) Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16 S rRNA gene sequencing and by microbiological culture. Arthritis Res Ther 9:R46
Desai M, Bühler T, Weller PH, Brown MR (1998) Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. J Antimicrob Chemother 42:153–160
Dunne WM Jr, Mason EO Jr, Kaplan SL (1993) Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 37:2522–2526
Dunne N, Hill J, McAfee P et al (2007) In vitro study of the efficacy of acrylic bone cement loaded with supplementary amounts of gentamicin: effect on mechanical properties, antibiotic release, and biofilm formation. Acta Orthop 78:774–785
Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE (1996) Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res (333):245–251
Editorial Comment (1919) Treatment of chronic osteomyelitis of traumatic origin. Ann Surg 69:72–84
El-Azizi M, Rao S, Kanchanapoom T, Khardori N (2005) In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob 4:2
Friedlaender GE (1991) Bone allografts: the biological consequences of immunological events. J Bone Joint Surg Am 73:1119–1122
Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW (2003) Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 1:667–683
Fux CA, Wilson S, Stoodley P (2004) Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model. J Bacteriol 186:4486–4491
Gattringer KB, Suchomel M, Eder M, Lassnigg AM, Graninger W, Presterl E (2010) Time-dependent effects of rifampicin on staphylococcal biofilms. Int J Artif Organs 33:621–626
Ghani M, Soothill JS (1997) Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa. Can J Microbiol 43:999–1004
Gonzalez Della Valle A, Bostrom M, Brause B, Harney C, Salvati EA (2001) Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement. Acta Orthop Scand 72:237–240
Gorur ALD, Schaudinn C, Costerton JW (2009) Biofilm removal with a dental water jet. Compend Contin Educ Dent 30:1–6
Greene N, Holtom PD, Warren CA et al (1998) In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from Simplex and Palacos. Am J Orthop 27:201–205
Gristina AG, Costerton JW (1985) Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am 67:264–273
Gristina AG, Oga M, Webb LX, Hobgood CD (1985) Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 228:990–993
Gristina AG, Jennings RA, Naylor PT, Myrvik QN, Webb LX (1989) Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci. Antimicrob Agents Chemother 33:813–816
Hazlett JW (1954) The use of cancellous bone grafts in the treatment of subacute and chronic osteomyelitis. J Bone Joint Surg Br 36-B:584–590
Jackson WO, Schmalzried TP (2000) Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res (381):101–105
Jamsen E, Stogiannidis I, Malmivaara A, Pajamaki J, Puolakka T, Konttinen YT (2009) Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop 80:67–77
Jefferson KK, Goldmann DA, Pier GB (2005) Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother 49:2467–2473
Katz J, Mukherjee N, Cobb RR, Bursac P, York-Ely A (2009) Incorporation and immunogenicity of cleaned bovine bone in a sheep model. J Biomater Appl 24:159–174
Khoo PPC, Michalak KA, Yates PJ, Megson SM, Day RE, Wood DJ (2006) Iontophoresis of antibiotics into segmental allografts. J Bone Joint Surg Br 88-B:1149–1157
Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M (1999) The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 14:339–346
Klemm K (1979) Gentamicin-PMMA-beads in treating bone and soft tissue infections (author’s transl). Zentralbl Chir 104:934–942
Konig DP, Schierholz JM, Munnich U, Rutt J (2001) Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants. Arch Orthop Trauma Surg 121:297–299
Lie SA, Havelin LI, Furnes ON, Engesaeter LB, Vollset SE (2004) Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register. J Bone Joint Surg Br 86:504–509
Marrie TJ, Costerton JW (1985) Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. J Clin Microbiol 22:924–933
Masri B, Duncan C, Beauchamp C (1998) Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty 13:331–338
Murillo O, Domenech A, Garcia A et al (2006) Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 50:4011–4017
Nelson CL, McLaren AC, McLaren SG, Johnson JW, Smeltzer MS (2005) Is aseptic loosening truly aseptic? Clin Orthop Relat Res (437):25–30
Neut D, van De Belt H, Stokroos I, van Horn JR, van Der Mei HC, Busscher HJ (2001) Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 47:885–891
Neut D, van der Mei HC, Bulstra SK, Busscher HJ (2007) The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop 78:299–308
Pitt WG, McBride MO, Lunceford JK, Roper RJ, Sagers RD (1994) Ultrasonic enhancement of antibiotic action on gram-negative bacteria. Antimicrob Agents Chemother 38:2577–2582
Prigge EK (1946) The treatment of chornic osteomyelitis by the use of muscle transplant of iliac graft. J Bone Joint Surg Am 28:576–593
Rediske AM, Hymas WC, Wilkinson R, Pitt WG (1998) Ultrasonic enhancement of antibiotic action on several species of bacteria. J Gen Appl Microbiol 44:283–288
Reynolds FC, Zaepfel F (1948) Management of chornic osteomyelitis secondary to compound fractures. J Bone Joint Surg Am 30:331–338
Rose WE, Poppens PT (2009) Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemother 63:485–488
Rothman RH, Cohn JC (1990) Cemented versus cementless total hip arthroplasty. A critical review. Clin Orthop Relat Res (254):153–169
Rowling DE (1970) Further experience in the management of chronic osteomyelitis. J Bone Joint Surg Br 52-B:302–307
Saginur R, Stdenis M, Ferris W et al (2006) Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 50:55–61
Smith AW (2005) Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 57:1539–1550
Smith K, Perez A, Ramage G, Gemmell CG, Lang S (2009) Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 33:374–378
Stephens R (1921) Osteomyelitis following was injureis: based on the sutdy of 61 cases. J Bone Joint Surg Am 3:138–153
Suci PA, Mittelman MW, Yu FP, Geesey GG (1994) Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 38:2125–2133
Trampuz A, Piper KE, Jacobson MJ et al (2007) Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357:654–663
Tunney MM, Ramage G, Patrick S, Nixon JR, Murphy PG, Gorman SP (1998) Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery. Antimicrob Agents Chemother 42:3002–3005
Tunney MM, Patrick S, Curran MD et al (1999) Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16 S rRNA gene. J Clin Microbiol 37:3281–3290
Tunney MM, Dunne N, Einarsson G, McDowell A, Kerr A, Patrick S (2007) Biofilm formation by bacteria isolated from retrieved failed prosthetic hip implants in an in vitro model of hip arthroplasty antibiotic prophylaxis. J Orthop Res 25:2–10
van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ (2000) Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation. Acta Orthop Scand 71:625–629
van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ (2001) Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 72:557–571
von Eiff C, Peters G, Becker K (2006) The small colony variant (SCV) concept – the role of staphylococcal SCVs in persistent infections. Injury 37(suppl 2):S26–S33
Walenkamp GH (2001) Gentamicin PMMA beads and other local antibiotic carriers in two-stage revision of total knee infection: a review. J Chemother 13(Spec No 1):66–72
Watanakunakorn C, Tisone JC (1982) Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 22:903–905
Widmer AF, Gaechter A, Ochsner PE, Zimmerli W (1992) Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 14:1251–1253
Winkler H, Janata O, Berger C, Wein W, Georgopoulos A (2000) In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother 46:423–428
Witso E, Persen L, Loseth K, Bergh K (1999) Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics. Acta Orthop Scand 70:298–304
Witso E, Persen L, Loseth K, Benum P, Bergh K (2000) Cancellous bone as an antibiotic carrier. Acta Orthop Scand 71:80–84
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279:1537–1541
Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645–1654
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Winkler, H. (2012). Treatment of Orthopedic Infections: Addressing the Biofilm Issue. In: Ehrlich, G., DeMeo, P., Costerton, J., Winkler, H. (eds) Culture Negative Orthopedic Biofilm Infections. Springer Series on Biofilms, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29554-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-29554-6_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29553-9
Online ISBN: 978-3-642-29554-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)